Top IT firms are racing to attract customers for their wearable tech advancements because of this promising future of the wearable business. Tech giants like Samsung, Apple, and Microsoft have released new products in recent years. And digital wearable health devices are showing promise in managing chronic conditions, promoting preventative healthcare, and improving patient engagement, according to research conducted in 2024.

Improvements in sensor technology, AI integration, and data analysis are also enabling more personalized and accurate health monitoring. However, there are still issues with data privacy, regulatory frameworks, and device validation that need to be resolved before these devices can reach their full potential. But today wearable devices are adding a new layer of both protection and vulnerability to our health and our health records.

When it comes to diagnosing and monitoring individuals, wearables might be useful. Worldwide health systems, like the National Health Service in England, have acknowledged the potential of wearable technology to aid with health care, and this acknowledgment has earned them a spot in the common strategic Long Term Plan. Wearables, however, are not just for patients’ specialized medical gadgets. For customers who are concerned about their health, top IT companies have started investigating wearable health devices.

With its January 2019 launch, the “NHS Long Term Plan” lays out NHS England’s goals for healthcare over the next decade, including how the organization will spend NHS funds to enhance patient care and health outcomes throughout the country.

According to a large body of research, wearables can help people take charge of their health by facilitating self-diagnosis, behavior modification, and monitoring. If the technology is to be used widely, it requires more promotion and support from providers to encourage uptake; more short-term investment to upskill employees, particularly in data analysis; and overcoming barriers to use, especially by improving device accuracy, are all factors that will contribute to greater wearable adoption and engagement.

Participatory health informatics (PHI) means considering the role of technology in assisting individuals with self-management and decision-making by also improving health literacy and the physician-patient relationship so that individuals can become more involved in the aspects of their health and care.

Historically, research in the PHI field has predominantly been based on social media and internet-based applications, with patient empowerment having been identified as the most common theme in this body of research. However, wearables are just beginning to be considered as part of PHI given recent technological advancements. Therefore, similar research is now required to examine whether wearables can empower individuals in ways similar to those regarding domains such as self-management, decision-making, and the physician-patient relationship.

And the inclusion of patient empowerment must also be calculated and addressed in a world where an almost collegial relationship is formed between patient and physician. This will be a major change from our past relationships where patients were poorly received once they began researching their illnesses on the Internet and questioned their healthcare provider. “Oh, you’ve been using Dr. Google, I see,” was a common put-down. Respect is receiving new consideration and pointing out our lapses in possible healthcare education and sensitive training toward patients must be required. Can challenging patients be acceptable, as formerly was the case?

Remote patient monitoring using wearables is becoming more important in light of the growing provider shortages that exacerbate geographically based disparities.

Where Do We Need Wearable?

One area of intense interest is related to patients with potential cardiac issues and here we note that much is yet to be accomplished for these patients. Only eight studies of the 31,12 papers retrieved from a systematic search were randomized controlled trials. The research was mostly focused on consumer-grade wearables that were modified to monitor heart failure (HF). The majority of these studies were conducted in the feasibility testing phase. Out of all the wearables that were mentioned, only two were approved by the FDA for HF RM (remote monitoring). A major obstacle to wearables’ incorporation into HF therapy is the lack of convincing evidence regarding their actual influence on HF management. This must be a concerning issue.

High expenses, low functional capacity and quality of life, and high rates of morbidity and mortality marked the complex and sometimes fatal syndrome known as heart failure. High expenses, low functional capacity and quality of life, and high rates of morbidity and mortality mark the complex and sometimes fatal syndrome known as heart failure (HF). Over 64 million individuals across the globe are impacted by HF and we do not truly know the total number because not everyone with potential HF has been identified. As a result, reducing its monetary and social impact has risen to the status of a top public health concern on an international scale. Therefore, this should be one of the aims of wearables — helping to reduce mortality.

But digitals have a whole host of potential uses currently that include fall detection, glucose monitoring, activity monitoring (steps tracking), sleep quality, blood pressure monitoring, and potentially high-risk pregnancies.

Unaddressed Issues of Wearables

Concerns about privacy and data sharing are only two of the many hazards and difficulties linked to wearable technology. The literature has mainly addressed technological or ethical concerns, treating them as distinct domains of study; nevertheless, wearables’ potential to enhance biomedical knowledge acquisition, development, and application has received scant attention.

Three areas that have been inadequately studied include screening, detection, and prediction. Screening involves searching through datasets obtained by monitoring for particular diseases and the people linked to them. Passive sensors that monitor things like motion, steps, light, pressure, sound, etc. are typically the basis of wearables used for this purpose.

One application of wearable technology is screening for sleep apnea by tracking the wearer’s heart rate and breathing patterns while they sleep. Detection is a process that is closely connected to screening. It is common practice to employ wearables to detect conditions and notify individual users when monitoring particular conditions in populations. Detection involves looking for patterns and features in the data gathered from wearable monitoring devices that could be indicative of certain medical disorders. Once we have this data, the possibility of greater detection of issues may emerge.

It is still very difficult to predict clinical outcomes following hospital discharge. There has been little success with strategies aimed at predicting and preventing death after discharge, readmissions, and trips to the emergency department (ED). Early interventions on modifiable risk variables might minimize morbidity, death, readmissions, and emergency department visits if predictive models could be improved. Wearable technology can monitor activity levels, sleep patterns, and tachy- or bradyarrhythmias, some of the modifiable risk factors for these clinical outcomes. Wearable digital devices might make significant differences in the ability to predict future health issues.

It has been shown that using more aspects of complex data from wearable technology would most likely enhance prediction models. One study that made use of 89 Fitbit data characteristics had an 88.3 percent success rate in predicting hospital readmission. Compared to other models, theirs performed far better in predicting readmission using typical retrospective clinical data.

Are digital, non-invasive wearables a viable and important contribution to healthcare now and in the future? Unquestionably, they are providing information as a continuous monitoring system in real-time and can prevent fatalities. The cost of the devices, availability, and insurance reimbursement will undoubtedly factor into how many patients can avail themselves of this technology. Lower-income patients and those in health deserts will be less likely to have access to them.

The post Wearable Tech Can Catch Health Issues Before Doctors appeared first on Medika Life.

Amidst this evolving demographic, the proliferation of smartphones, wearable health monitoring devices, telemedicine, and other health-tech applications driven by today’s digital age has transformed the way consumers engage with healthcare. This has given rise to an increasingly informed patient population who are constantly looking for ways to take their health into their own hands and on the alert for innovative self-management solutions.

Against this backdrop, we are seeing a steadily rising sector in the healthcare industry that has been gaining momentum – Consumer Healthcare (CHC).  Offering affordable and accessible options for preventive care and symptom management, the CHC sector is designed to provide easily accessible services for consumers such as over-the-counter medications, personal care items, and supplements. Having reached a value of USD 284.16 billion in 2022, the global CHC market is projected to soar to USD 608.39 billion by 2032, growing at a promising trajectory of 7.91% CAGR[3]. From a SEA context, CHC represents a captivating prospect for mitigating its demographic hurdles while unlocking growth opportunities for healthcare enterprises. Here’s how healthcare businesses can tap into this potential and leverage CHC to improve patient outcomes.  

The Perfect Storm: Challenges Driving CHC Demand in APAC

There are two key challenges creating a surge in CHC demand, with the first being growing non-communicable diseases (NCDs) in the region.

NCDs are a leading cause of mortality in SEA, responsible for approximately 62% of all deaths annually, and totalling around 9 million lives lost[4]. Alarmingly, half of these deaths occur among individuals aged 30 to 69 years, highlighting the significant impact on the productive age group[5]. Among NCDs, cardiovascular diseases (CVDs) claim the highest number of lives (3.9 million deaths), followed by cancers, chronic respiratory diseases, and diabetes.  Moreover, rapid urbanization has led to lifestyle changes characterized by sedentary behaviour, unhealthy diets, as well as increased tobacco and alcohol consumption. Traditional diets are being replaced by high-calorie, low-nutrient foods, contributing to obesity, hypertension, and diabetes. Additionally, despite efforts to curb tobacco consumption, smoking rates remain the highest (26.5%) in SEA[6]. Alcohol consumption is also increasing, particularly among young adults. Along with diagnosed cases, there is a substantial portion of the population living in rural areas of SEA with undiagnosed NCDs and who are unable to afford treatment. These factors point to a considerable unmet need for NCD-specific treatments and diagnostics to address the growing burden of these diseases in the region.

The burgeoning NCD burden in Southeast Asia highlights a critical need for accessible and affordable treatments and diagnostics. CHC products have the potential to fill this market gap, offering viable solutions to address the escalating prevalence of NCDs in the region.

Secondly, the heavy NCD burden is coupled with a critical shortage of trained healthcare professionals in the region, with insufficient doctors, nurses, and other medical personnel available to meet the healthcare needs of its population. For example, Indonesia faced a staggering deficit of 31,481 specialist doctors in 2023[7]. In the same year, the Philippines health department said that the country needed 125,890 nurses and 116,032 doctors to meet WHO standards, and it would take 25 years to close the doctor-patient demand gap[8]. As a result, patients may face long wait times for appointments, limited access to specialized care, and challenges in receiving timely medical attention. Furthermore, the shortage can lead to overburdened healthcare facilities, increased workloads for existing staff, and compromised quality of care as professionals feel burnout[9]. This exacerbates healthcare disparities and hampers efforts to ensure equitable access to healthcare.

Given SEA’s shortage of healthcare professionals, there is an urgent call for accessible and self-directed healthcare options. With the increasing demand for CHC products amidst these hurdles, the CHC sector offers a hopeful means to narrow the healthcare access divide and enable individuals to manage their health proactively.

Bridging the Gap: CHC’s Transformative Power

CHC also provides a wealth of benefits that cater to the region’s dynamic needs. One significant advantage of CHC is its appeal to the rising middle-class population in the Asia-Pacific region. By 2030, Asia Pacific’s (APAC) middle-class population is projected to grow from 1.38 billion in 2015 to 3.49 billion[10], indicating a surge in consumers with increased disposable income who prioritize personal well-being. In addition, 51% of APAC consumers are willing to pay more out of pocket for healthcare, while 50% of high-income groups are spending more on nutritional supplements[11]. This demographic shift underscores the growing demand for health-related products and services, positioning CHC as a key player in meeting evolving consumer needs.

Additionally, CHC products have the potential to overcome geographical barriers and reach underserved areas where traditional healthcare services are lacking. More than one-third – 1.6 billion – of the APAC population lack effective access to social health protection, and less than half of its workforce enjoys legal entitlement to income security in the face of illness[12]. Due to inadequate infrastructure, CHC can provide essential over-the-counter medications and healthcare essentials in remote and rural communities with limited access to clinics and hospitals. Within these communities, chain pharmacies, personal care stores, hospitals, and clinics can function as essential healthcare nodes, acting as the first point of contact for medical care and self-care. CHC products and OTC medicines, therefore, ensure that healthcare remains accessible to all.

Moreover, CHC can empower individuals to take control of their health through proactive self-care practices and readily accessible OTC solutions. By promoting preventive measures and offering easy access to healthcare products, CHC fosters a culture of health-consciousness and empowerment among consumers.

The Road Ahead: Collaboration and Strategic Partnerships

In charting the road into SEA’s CHC industry, collaboration amongst key stakeholders emerges as the cornerstone for advancing healthcare access and ensuring the seamless delivery of quality products and services to patients across the region. This includes strategic partnerships amongst healthcare providers, CHC companies, and governmental organisations.

For CHC companies looking to drive accessibility of their products, the relevant stakeholders must set up efficient distribution channels to ensure the seamless delivery of CHC solutions to underserved populations, particularly in remote and rural areas. CHC companies can do this by partnering with service providers who have a strong understanding of SEA’s market complexities, strong market expansion services, and an extensive delivery infrastructure catered to the region’s specific needs. For example, DKSH Healthcare’s capillary distribution network has a 90% penetration in CHC with over 100 years of experience in Asia, with strong reach into chain and independent pharmacies, convenience stores, supermarkets, and hypermarkets.

Additionally, navigating the intricate regulatory landscapes of SEA emerges as a pivotal challenge. Here, partnering with companies that boast extensive regulatory expertise becomes essential. Such partnerships facilitate the negotiation of diverse regulatory frameworks, ensuring compliance with stringent standards while expediting the introduction of CHC products to the market. DKSH Healthcare’s team of 90 healthcare experts provided end-to-end assistance on regulatory challenges to help businesses adhere to compliance standards, while ensuring that patient safety takes priority. Thus, collaborative efforts among stakeholders herald a promising trajectory for CHC in SEA, bolstering healthcare accessibility and efficacy across the region.

Towards a Consumer-Driven Future for Healthcare

As the region continues to navigate healthcare disparities and demographic shifts, the rise of CHC emerges as a transformative force in addressing pressing challenges. By empowering individuals to take charge of their well-being and bridging gaps in healthcare access, CHC also paves the way for a brighter, healthier future in Southeast Asia. With the support of collaborative initiatives, it’s time for CHC business and healthcare organizations to tap into CHC’s potential to revolutionize healthcare accessibility and efficacy across the region, paving the way for a consumer-driven future in healthcare.

[1] https://www.worldometers.info/world-population/south-eastern-asia-population/#:~:text=South%2DEastern%20Asia%20Population%20(LIVE)&text=The%20current%20population%20of%20South,the%20latest%20United%20Nations%20estimates.

[2] https://asia.nikkei.com/Spotlight/Datawatch/Aging-Southeast-Asia-grapples-with-weak-social-safety-nets#:~:text=In%202019%2C%20the%20ratio%20of,to%20the%20%22aged%22%20category.

[3] https://www.who.int/southeastasia/health-topics/noncommunicable-diseases#:~:text=Noncommunicable%20diseases%20(NCDs)%2C%20principally,accounting%20for%209%20million%20persons.

[4]  https://www.who.int/southeastasia/health-topics/noncommunicable-diseases#:~:text=Noncommunicable%20diseases%20(NCDs)%2C%20principally,accounting%20for%209%20million%20persons.

[5]  https://www.who.int/southeastasia/health-topics/noncommunicable-diseases#:~:text=Noncommunicable%20diseases%20(NCDs)%2C%20principally,accounting%20for%209%20million%20persons.

[6] https://www.who.int/news/item/16-01-2024-tobacco-use-declines-despite-tobacco-industry-efforts-to-jeopardize-progress

[7] https://www.integrity-indonesia.com/blog/2023/10/10/overcoming-medical-workforce-shortages-opportunities-and-challenges-for-foreign-doctors-in-indonesia/#:~:text=According%20to%20a%20report%20from,serving%20a%20population%20of%20277%2C432%2C360.

[8] https://www.philstar.com/headlines/2023/11/13/2311040/ideal-patient-doctor-ratio-seen-25-years-lawmaker

[9] https://www.bmj.com/content/382/bmj.p1655

[10] https://www.statista.com/statistics/255591/forecast-on-the-worldwide-middle-class-population-by-region/

[11] https://www.bain.com/about/media-center/press-releases/2024/asia-pacific-consumers-especially-gen-z-are-taking-greater-ownership-in-health-and-well-being-bain-survey-finds/

[12] https://www.ilo.org/asia/media-centre/news/WCMS_831314/lang–en/index.htm

The post The Rise of Consumer Health in Shaping Southeast Asia Treatment Accessibility   appeared first on Medika Life.

The McCormick Conference Center has enthusiastic attendees, filling session rooms and the exhibit hall.  But the meeting’s focus and content – along with the recognition that the pandemic and economy require new thinking and approaches to health information and health-tech innovation.  What HIMSS lacks in meeting SWAG, it more than makes up for in nuts-and-bolts content on integrating bold ideas and new inventions into the healthcare system.  That’s its differentiator in a sector that seems to be adding more and more gatherings.

SESSION ROOMS ARE FILLED – WHY? ATTENDEES SEEK TO LEARN AND APPLY!

How does HIMSS plan its content sessions – which are peer-review selected – through the tireless work of its staff and volunteers who pour over countless (and largely excellent) submissions to drill down to the hundreds that reach the program.  Despite the number of concurrent sessions, the rooms are packed, reinforcing why people come to HIMSS23 – to listen and learn!

PROBLEMS AND SOLUTIONS!

For years, people in the health sector have talked about its growing fragmentation.  As fast as companies invent new information systems and technologies, new problems arise with integration and security.  The puzzle pieces are proliferating but have yet to bring the ecosystem closer. Health professional burnout has been the constant refrain from physicians and the COVID staff drop-out rate has been as alarming as the alert bells pinging at nursing stations.

The tone and content at HIMSS23 reflected the need to stop concentrating on the problems and new ideas and center around solutions.  Keynotes such as Tom Lawry, a long-time Microsoft AI leader and now a “recovering alum,” and John Whyte, MD, chief medical officer of WebMD, led and moderated sessions that shifted to the practical use of information in the care setting. Not new ideas but how to better leverage and apply tools to improve workflow and patient care.

The meeting was also more global in perspective.  For example, Whyte’s session on the Quest for the Perfect Healthcare System – How Do We Get There? Wisely compared the UK’s favored National Health System to the “highly remunerated USA system and everything in between.” There is a hunger to use HIMSS as a pathway to better (best is far off) practices. At the same time, Lawry brought leading minds in AI together from health systems that employ the tool to reach patients most at risk and shift their attention from sick care to deploying preventive health care.

THE HIMSS EXHIBIT FLOOR FOCUSES ON PRACTICAL SOLUTIONS

The exhibit floor has been packed wall-to-wall with booths that are as educational as the sessions themselves.  Many of the breaking ideas in the news – some that justifiably frighten society, such as AI and ChatGPT – showed their more practical, life-saving side.  While health and home and wearables that collect and transmit personal information become the new doctor’s black bag, some companies exhibiting are seeking to resolve problems that should keep us up at night, such as cybersecurity and data protection.

Here are some of the hundreds of companies exhibiting that caught my eye. Others should explore what others in the sectors are doing to make new ideas and inventions into practical (and necessary) tools to leverage current systems.

FORGET THE AI AND CHATGPT BUZZ – COMPANIES ARE DELIVERING SOLUTIONS NOW

Health at home is less expensive and preferred.  But can it work with people with more serious medical needs?  ATLASense provides ICU-level monitoring in the home; it is wireless and simulates the predictive capabilities of an attentive onsite nurse. Using 15 sensors and measuring 50 biomarkers, it’s a small, wearable medical device that is reusable. The data flow to health professionals overseeing care offers a pathway to send people from acute care to a place that supports healing.  

Patients must be part of the care conversation.  That has long been the mantra of the patent community and has recently been acknowledged by drug development and payer systems.  Belong Life is among the world’s more extensive patient navigation and social networks for cancer and multiple sclerosis (MS) patients. The platform is used by nearly 1 in 10 cancer patients and 1 in 5 MS patients.

What’s new is its AI Mentor and ChatGPT patient system. The company – driven by compassion and confidentiality – has a model that makes a virtual community practical for people with these serious health concerns. With this new AI effort, Contract Research Organizations and their pharma sponsors should take note of a pathway to better understand what people need and want.

The Internet of Medical Things (IoMT) describes the network of physical objects — “medical things”— embedded with sensors, software and other technologies.  Today, devices are found within 75% of connected assets in hospital systems.  These technologies are a boost to patient convenience and provider care.  And they pose a great cybersecurity danger – a real medical risk to patients.  Hospitals are notoriously vulnerable to hacking. 

IoMT is an easy target for cyber attackers and is among the more worrisome unaddressed cybersecurity risks to medical networks.  Cylera is becoming a global go-to partner to guard against these clear and present dangers using forms of AI and to create a digital twin that assesses IoMT devices to remediate discovered risks.

Health systems are experiencing a challenging financial year – even shuttering doors in remote areas where care is desperately needed. Predictions are that only “must-have” technologies will be considered going forward. Given this backdrop, HIMSS23 conversations focused on technologies that automate existing manual processes to reduce costs.  

This is especially important in revenue cycle management, where providers experience staff shortages and shrinking margins. FinThrive shows health system CIOs the pathways to invest in intelligent, integrated technologies that automate revenue cycle operations. The company connects the revenue cycle teams through a SaaS platform to make collaborative decisions.

Hospital at home is the fastest-growing US care pathway. Keeping people at home after discharge is the desired outcome.  Putting that into practice is the challenge.  Honeywell is taking a practical approach to how AI can move health systems from patient vitals data collection to smarter, faster clinical decision-making. Here is a real-time monitoring system that captures patients’ vital signs within a hospital and remotely. The “Real-Time Health System” (RTHS) uses a wireless QR code skin patch for real-time monitoring. The patch connects to an intelligent app and caregivers receive real-time alerts of significant patient status changes.  Along with propping up pillows and tracking med times, home caregivers become partners in care delivery and people can heal at home safely.

Among the more challenging health intersections is between providers and payers. The tussle for reimbursement requests is friction, repetitive work and outdated workflow. MRO is improving the complex relationship between providers and payers through more thoughtful patient information and clinical data exchange.  Streamlining back-end workflows between providers and payers is a data handshake between financial decision-makers to improve interoperability and intelligent solutions to reduce provider-payer friction.

The real-time sharing of patient insights is a constant HIMSS23 call to action.  The system collects volumes of information.  But “after the fact” analysis means the barn gate on a patient’s care closes by the time the data are assessed.  Effective data-driven care coordination is mission-critical for providers and health plans as they shift to value-based programs. PointClickCare seeks to facilitate better care by tapping one of the most underutilized and required assets – collaboration. 

In connecting data from more than 27,000 long-term and post-acute care providers, more than 2,800 hospitals and 2,000 ambulatory clinics, every major health plan across the US, and some 75 state and government agencies, this is an example of how information can piece together the fragmented health ecosystem.

Interoperability remains a distant desire. SEQSTER, a pioneer in patient-centric healthcare data technology and patient management, announced its partnership with CLEAR, the secure identity platform to provide patients with Individual Access Services.  Announced during HIMSS23, the platform enables consumers to confirm their identities, access medical records and safely share them with various clinical trial research organizations within the SEQSTER Operating System for healthcare.

Health information for consumers and providers remains key to people’s health and wellbeing. Front and center on the exhibit floor is WebMD. The company used HIMSS23 to launch WebMD Ignite offering a comprehensive suite of healthcare solutions to kickstart healthcare organizations’ efforts to improve engagement and fuel growth through every stage of the healthcare journey, from discovery to recovery.  The solutions are the culmination of curated acquisitions from leading healthcare companies within the WebMD Health Network – including WebMD Provider Services, Krames, Mercury Healthcare, and The Wellness Network. 

THE POWER OF NOW

The combination of COVID, recognizing that the system is awash in data and spiraling health costs, and looming cyber risks that make health data vulnerable, is shifting business and medical leaders to advocate for immediate solutions.

HIMSS23 continues to be the meeting ground for government officials, mega-companies, and start-ups to see each other more as collaborative partners than competitors in the system’s improvement.  What was historically the playground of ideas and inventions has transformed into the roll-up-the-sleeves community. The conversations have been less about the system’s shortfalls and more about fixes that improve access, reimbursement and keeping people out of the hospital or getting them home faster. 

One thing that hasn’t changed is the refrain that the consumer is the customer.  That’s not the case.  The system itself remains the primary focus of the industry.  The outcome of a viable, more accessible health system that uses the information to perform cost-effectively will benefit the ecosystem – including the people that seek healing.

The post #HIMSS23 Brings Renewed Energy to the Global Health Information Table appeared first on Medika Life.

It’s happening now. And healthcare is at the center of this revolution of care driven by technology, the empowered consumer, and dimensionalized  by retail to drive both services and the creation of a new and more optimal user experience. The many and varied digital health tools that are available today—blood glucose monitoring to advanced analytics—can add an expanded dimension to the utility and convenience that redefine fundamental aspects of care.

Technology with a human touch.

Technological advances are providing unparalleled opportunities for medicine and digital health, giving rise to new capabilities which are making it possible to deliver personalized medicine and preventive care at unprecedented levels. Wearable devices such as fitness trackers can provide real-time data about users’ health, allowing doctors to monitor their progress or identify potential issues before they become serious problems. Together, devices with AI-based insights become greater than the sum of the parts and make drive essential clinical utility

Further, the power of technology, including advanced analytics and artificial intelligence, will enable clinical stakeholders to operate at expanded levels of competence. The roles of the nurse, pharmacist, and other HCPs will expand to tackle pressing human issues including fatigue and burnout.

Humanity with a technology edge.

At the heart of this transformation is the user experience, or perhaps better articulated as a human experience. By making technology more user-friendly and intuitive, healthcare providers can make it easier for patients to access the care they need and to understand the information they are provided with. This can help to reduce anxiety and improve overall satisfaction with the healthcare experience. Additionally, this can help to reduce errors and improve the accuracy and reliability of medical information, which can ultimately lead to better outcomes for patients. By using devices such as wearables and telemedicine, patients can get the care they need without having to leave home. Additionally, designing healthcare facilities with a focus on comfort and accessibility can also help make the experience more human-centered. And by providing compassionate, personalized care and support, we can ensure that each person is treated with dignity and respect.

Today, there’s an interesting example of emerging technology call GPT-3 (short for “Generative Pre-trained Transformer 3”).  GPT-3 works by training a large neural network on a dataset of human-generated text, such as books, articles, and websites. The neural network is designed to predict the next word in a sequence of words, given the context of the previous words. As the model is trained, it “learns” the patterns and structures of the language and can generate new text that follows those patterns.

There are several potential applications for GPT-3 in the field of medicine. For example, the model could be used to generate medical reports, summarizing patient information and test results for physicians and other medical professionals. Additionally, GPT-3 could potentially be used to improve natural language processing (NLP) systems for electronic health records (EHRs), allowing physicians and other HCPs to more easily search and analyze patient data. NLP systems that can understand and extract information and could help improve the efficiency and accuracy of medical decision-making. And perhaps most remarkable is the ease of use of these platforms.

The convergence of these areas of innovation—human and technological—is leading to fundamental changes in the way healthcare is delivered, with the potential for transformative effects on patient outcomes and cost savings. The cooperative engagement of man and machine is becoming less a “force fit” and more a “create dance” that celebrates this new relationship.

The post The Era Of Humanology appeared first on Medika Life.

We also talked about health systems and the best way to close the gaps to leverage technology in order to improve healthcare delivery.

Connect with Dr. Rafael Grossman
LinkedIn | Twitter

Please check our Global Partners – Spirit Digital Website – Incredible Remote Monitoring and Digital Health Solutions with CliniTouch Vie – Technology enabled care for patients with long-term conditions.

The post The Wearables Expert ™ Interviews Dr. Rafael Grossman, MD appeared first on Medika Life.

Connect with Dr. John Whyte
LinkedIn | Twitter

Please check our Global Partners – Spirit Digital Website – Incredible Remote Monitoring and Digital Health Solutions with CliniTouch Vie – Technology enabled care for patients with long-term conditions.

The post The Wearables Expert ™ Interviews Dr. John Whyte appeared first on Medika Life.

We also talked about the impact in healthcare, how can we measure impact in Healthcare in any way? Furthermore, the importance of having organizations that are able to tie all these things together without touching the underlying systems.

Connect with Lucien Engelen
LinkedIn | Twitter

Please check our Global Partners – Spirit Digital Website – Incredible Remote Monitoring and Digital Health Solutions with CliniTouch Vie – Technology enabled care for patients with long-term conditions.

The post The Wearables Expert ™ Interviews Lucien Engelen appeared first on Medika Life.

In this episode, we talked about Digital Health​​, AMR​ & Patient Communication​ Viewers can learn and get insights into Vanessa’s Journey and her multiple challenges after a car accident, including dealing with medication intolerance and lack of clinicians’ communication.

Furthermore, you can also learn what ( AMR ) Antimicrobial Resistance is and its effects, as well as how technology can be used to improve patient communication.

Connect with Vanessa Carter
LinkedIn | Twitter

Please check our Global Partners – Spirit Digital Website – Incredible Remote Monitoring and Digital Health Solutions with CliniTouch Vie – Technology enabled care for patients with long-term conditions.

The post The Wearables Expert ™ Interviews Vanessa Carter appeared first on Medika Life.

In this episode, we talked about Digital Health​, NHS​ & Remote Monitoring.​ Viewers can learn and get insights about barriers to enter the NHS in the UK, expectations, and evidence needed in order to be successful.

Furthermore, you can also find great insights about remote monitoring and what successful healthcare innovation looks like. We also talked about the importance of understanding the context of health, and particular healthcare systems as they vary around the world from country to country.

Connect with Chris Barker
LinkedIn | Twitter

Please check our Global Partners – Spirit Digital Website – Incredible Remote Monitoring and Digital Health Solutions with CliniTouch Vie – Technology enabled care for patients with long-term conditions.

The post The Wearables Expert ™ Interviews Chris Barker appeared first on Medika Life.

In this episode, we talked about Digital Health​ and Artificial Intelligence​ Viewers can learn and get insights into the digital health marketplace, addressing readiness, adoption, and maturity.

Our discussion covers the state of Artificial Intelligence and its hype. Artificial Intelligence is often overused within the industry, Dr. Ali Parsa demystifies it by acknowledging that AI is in its infancy. Also, we talked about accessibility, affordability, and the pandemic as an event to be a platform to do something different in the future.

Connect with Dr. Ali Parsa
LinkedIn | Twitter

Please check our Global Partners – Spirit Digital Website – Incredible Remote Monitoring and Digital Health Solutions with CliniTouch Vie – Technology enabled care for patients with long-term conditions.

The post The Wearables Expert ™ Interviews Dr. Ali Parsa appeared first on Medika Life.